Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Ovarian Injection for Poor Ovarian Response
NCT05105724Phase 2Unknown
- Sponsor
- Nanjing University
- Start
- Jul 2019
- Primary completion
- Jul 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of platelet-rich plasma in poor ovarian response (POR) (2 arms), sponsored by Nanjing University. Primary endpoint: Number of oocytes retrieved at 30 days. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT05105724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05105724.